Buy Inter Parfums (IPAR) on Weakness, BWS Financial Says

BWS Financial analyst Hamed Khorsand reiterated a Buy rating and $45 price target on Inter Parfums (NASDAQ: IPAR), saying there has been no change in the story and is recommending investors buy the weakness.

Khorsand notes Q2 results were in-line but investors are focused on the slowdown in Europe and decline in gross margin as troubles IPAR could face in ensuing quarters. The analyst said investors should look to the number of new products coming in the 2nd-half.

"The difference between the second quarter and the rest of the year is the introduction of a handful of products between now and the rest of the year," he said. "New products tend to provide a lift to revenue and earnings as it is sold through distribution."

For an analyst ratings summary and ratings history on Inter Parfums click here. For more ratings news on Inter Parfums click here.

Shares of Inter Parfums closed at $30.03 yesterday.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Glenmark Pharmaceuticals Ltd. (GNP:IN) PT Raised to INR2,750 at Investec
• Nomura/Instinet Upgrades SK Innovation Co Ltd (096770:KS) to Neutral